Research Article
[Retracted] Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
Table 1
General clinical information.
| Category | Research group (n = 40) | Control group (n = 38) | t/χ2 value | value |
| Sex | Male | 24 (60.00) | 20 (52.63) | 0.430 | 0.511 | Female | 16 (40.00) | 18 (47.37) | Age (years) | 53.16 ± 14.04 | 52.64 ± 13.75 | 0.165 | 0.869 | BMI (kg/m2) | 23.62 ± 2.13 | 23.55 ± 2.25 | 0.141 | 0.888 | Course of diabetes | 9.86 ± 3.14 | 9.21 ± 3.38 | 0.880 | 0.381 | NVG staging | I | 28 (70.00) | 25 (65.79) | 0.158 | 0.690 | II | 12 (30.00) | 13 (34.21) | Marital status | Married | 24 (60.00) | 26 (68.42) | 0.600 | 0.438 | Single | 16 (40.00) | 12 (31.58) | Residence | Urban | 18 (45.00) | 17 (44.74) | 0.001 | 0.981 | Rural | 22 (55.00) | 21 (55.26) | Educational background | ≥ High school | 9 (22.50) | 10 (26.32) | 0.154 | 0.694 | < High school | 31 (77.50) | 28 (73.68) | History of smoking | Yes | 14 (35.00) | 15 (39.47) | 0.167 | 0.682 | No | 26 (65.00) | 23 (60.53) | History of hypertension | Yes | 29 (72.50) | 25 (65.79) | 0.412 | 0.521 | No | 11 (27.50) | 13 (34.21) |
|
|